Supplemental material
Report
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo
Lisa Nadala Biology department, Philochem AG, Otelfingen, Switzerland;b CiBIO (Department of Cellular, Computational and Integrative Biology, University of Trento, Italy, Trento, Italy
https://orcid.org/0000-0002-8566-103XView further author information
https://orcid.org/0000-0002-8566-103XView further author information, Riccardo Corbellaria Biology department, Philochem AG, Otelfingen, Switzerland;b CiBIO (Department of Cellular, Computational and Integrative Biology, University of Trento, Italy, Trento, Italyhttps://orcid.org/0000-0001-6126-5641View further author information
https://orcid.org/0000-0001-6126-5641View further author information, Alessandra Villaa Biology department, Philochem AG, Otelfingen, Switzerlandhttps://orcid.org/0000-0003-4070-286XView further author information
https://orcid.org/0000-0003-4070-286XView further author information, , , Dario Nerid Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerlandhttps://orcid.org/0000-0001-5234-7370View further author information
https://orcid.org/0000-0001-5234-7370View further author information & Roberto De Lucaa Biology department, Philochem AG, Otelfingen, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0001-7519-8689View further author information
https://orcid.org/0000-0001-7519-8689View further author information show all